Clorazepate Dipotassium recalls

The FDA has published 2 recalls involving Clorazepate Dipotassium since 2024. The latest was reported on 15 May 2024. Recalls usually affect specific lots, not every bottle on the market. Check the lot number on each recall page before acting.

Total recalls2since 2024
Last 12 months0reported
Class I00% of total
Ongoing2latest 15 May 2024

Recalls per month, last 24 months

click a bar for that month

Severity split

Class I 0 0%Class II 2 100%Class III 0 0%

Why clorazepate dipotassium is recalled

Companies

By year

Ongoing clorazepate dipotassium recalls

2 active
ReportedClassRecallCompanyReasonWhere
DrugCLASS IIClorazepate Dipotassium Tablets, USP, 3.75 mg, a) recalledClorazepate DipotassiumAurobindo Pharma USAOtherNationwide
DrugCLASS IIClorazepate Dipotassium Tablets, USP, 7.5 mg, a) recalledClorazepate DipotassiumAurobindo Pharma USAOtherNationwide

All clorazepate dipotassium recalls, newest first

2 total
ReportedClassRecallCompanyReasonWhere
DrugCLASS IIClorazepate Dipotassium Tablets, USP, 3.75 mg, a) recalledClorazepate DipotassiumAurobindo Pharma USAOtherNationwide
DrugCLASS IIClorazepate Dipotassium Tablets, USP, 7.5 mg, a) recalledClorazepate DipotassiumAurobindo Pharma USAOtherNationwide

Should you stop taking Clorazepate Dipotassium?

Not on your own. Most recalls affect specific lots from one manufacturer, and stopping a prescription suddenly can be riskier than the defect. Check your lot number and NDC against the recall, then call the pharmacy that dispensed it for a replacement.